½ÃÀ庸°í¼­
»óǰÄÚµå
1595314

ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå : ¼ÒÀ纰, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Pharmaceutical Contract Packaging Market by Material (Aluminum Foil, Glass, Paper & Paperboard), Application (Ampoules, Blister Packs, Bottles) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 320¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 348¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.91%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 583¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Á¦¾à À§Å¹Æ÷ÀåÀº Á¦¾àȸ»ç°¡ Á¦3ÀÚ °ø±Þ¾÷ü¿¡ Æ÷Àå ¼­ºñ½º¸¦ ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÀÌ »ê¾÷Àº Á¦¾àȸ»ç°¡ ÀǾàǰ °³¹ß ¹× ¸¶ÄÉÆÃ°ú °°Àº ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÏ´Â µ¿½Ã¿¡ ¾÷°è Ç¥ÁØ ¹× ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇÏ´Â µ¥ ÀÖ¾î ¼öŹ Æ÷Àå ¾÷üÀÇ Àü¹® Áö½Ä°ú ¿ª·®À» Ȱ¿ëÇÒ ¼ö Àֱ⠶§¹®¿¡ ÇʼöÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. ¼öŹ Æ÷ÀåÀÇ Çʿ伺Àº ÀǾàǰ Á¦Çü ¹× Æ÷Àå ¿ä°ÇÀÇ º¹À⼺ Áõ°¡, ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã °­È­, Áö¼Ó °¡´ÉÇÑ Æ÷Àå ¼Ö·ç¼ÇÀÇ È®»ê¿¡ ±âÀÎÇÕ´Ï´Ù. ¼öŹ Æ÷ÀåÀÇ ¿ëµµ´Â ¹°Áý Æ÷Àå, º´ ÃæÀü, ¶óº§¸µ, 2Â÷ Æ÷Àå µîÀ» Æ÷ÇÔÇϸç, ÃÖÁ¾ ¿ëµµ´Â ¼öŹ Á¦Á¶ ±â°ü(CMO)¿¡¼­ ÀÏ¹Ý ÀǾàǰ(OTC) ¹× ÀÇ·á¿ë ÀǾàǰÀ» Á¦Á¶ÇÏ´Â Á¦¾àȸ»ç¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 320¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 348¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 583¾ï ´Þ·¯
CAGR(%) 8.91%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é, ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â Çõ½ÅÀûÀÎ Æ÷Àå ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦ ¹× Ư¼ö ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¦¾à »ê¾÷ÀÇ ¾Æ¿ô¼Ò½Ì Æ®·»µå Áõ°¡, ½Ã¸®¾ó¶óÀÌÁ¦ÀÌ¼Ç ¹× ÃßÀû ½Ã½ºÅÛ°ú °°Àº Æ÷Àå ±â¼úÀÇ ¹ßÀü µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °ü°èÀڵ鿡°Ô´Â ģȯ°æ ÆÐŰ¡ ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇÑ ¼­ºñ½º Æ÷Æ®Æú¸®¿ÀÀÇ È®´ë, ÆÐŰ¡ ÇÁ·Î¼¼½º °£¼ÒÈ­¸¦ À§ÇÑ µðÁöÅÐ ±â¼ú µµÀÔ µîÀÌ ºñÁî´Ï½º ±âȸ·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à »ê¾÷ÀÌ ¼ºÀåÇϰí ÀÖ´Â ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ Áö¸®Àû È®ÀåÀº À¯¸®ÇÑ Àü¸ÁÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ±î´Ù·Î¿î ±ÔÁ¦ ¿ä°Ç, ºñ¿ë ¾Ð¹Ú, ¼¼°è °æÁ¦ÀÇ ºÒÈ®½Ç¼ºÀ¸·Î ÀÎÇÑ ¼ö¿ä º¯µ¿¼º µîÀº °úÁ¦·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀÇ Àü¸ÁÀº ȯÀÚÀÇ º¹¾à ¼øÀÀµµ¸¦ ³ôÀ̰í, °ø±Þ¸Á Åõ¸í¼ºÀ» °³¼±Çϸç, ÀÎÁõÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â ½º¸¶Æ® Æ÷Àå ¼Ö·ç¼ÇÀÇ °³¹ß¿¡ ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º Àç·á¿Í ÀçȰ¿ë °¡´ÉÇÑ Àç·á¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸´Â °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϸç, ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú ±ÔÁ¦ º¯È­·Î ÀÎÇØ ¿ªµ¿ÀûÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. Áö¼Ó °¡´ÉÇÑ ºñÁî´Ï½º ¼ºÀåÀ» À§ÇØ ±â¾÷Àº ÷´Ü ±â¼ú¿¡ ÅõÀÚÇϰí, Àü·«Àû ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ¸¦ ÅëÇØ ¼­ºñ½º Á¦°øÀ» °­È­ÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ÄÄÇöóÀ̾𽺿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±Ù°ú °í°´ÀÇ °íÀ¯ÇÑ ´ÏÁî¿¡ ´ëÇÑ ±íÀº °ü½ÉÀº ÁøÈ­ÇÏ´Â ½ÃÀå¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í ±âȸ¸¦ Æ÷ÂøÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® ÆÄ¾Ç

Á¦¾à ¼öŹ Æ÷Àå ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¦¾à »ê¾÷¿¡¼­ Æí¸®ÇÏ°í º¯Á¶ ¹æÁö Æ÷Àå¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
    • ¼¼°è ÀǾàǰ Á¦Á¶ ¹× ¼öÃâ Áõ°¡
    • ÀǾàǰ Æ÷Àå¿¡ ´ëÇÑ Á¤ºÎÀÇ ¾ö°ÝÇÑ ±âÁØ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °íµµÀÇ ¸ÂÃãÇü ÀǾàǰ ¼öŹ Æ÷Àå ¼­ºñ½ºÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÀǾàǰ Æ÷Àå ¼Ö·ç¼ÇÀÇ ±â¼úÀû Áøº¸
    • ½Å¾à°³¹ß¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ
  • ½ÃÀå °úÁ¦
    • ½Å°³¹ß ÀǾàǰ°ú Æ÷ÀåÀç ¹× À§Á¶Ç° ±¤°í¿ÍÀÇ °æÀï

Portre's Five Forces: ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀǾàǰ À§Å¹Æ÷Àå ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀǾàǰ À§Å¹Æ÷Àå ½ÃÀå¿¡¼­ÀÇ °æÀï»óȲ ÆÄ¾Ç

Á¦¾à ¼öŹ Æ÷Àå ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå¿¡¼­ÀÇ ¼º°ø Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

Á¦¾à ¼öŹ Æ÷Àå ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå : ¼ÒÀ纰

  • ¾Ë·ç¹Ì´½ Æ÷ÀÏ
  • À¯¸®
  • Á¾ÀÌ ¹× ÆÇÁö
  • ÇÃ¶ó½ºÆ½ ¹× Æú¸®¸Ó

Á¦7Àå ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå : ¿ëµµº°

  • ¾ÚÇÃ
  • ºí¸®½ºÅÍ ÆÑ
  • º¸Æ²
  • ¹ÙÀ̾Ë

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • AbbVie Inc.
  • Almac Group
  • AmeriPac, Inc.
  • Aphena Pharma Solutions Inc.
  • Assemblies Unlimited Inc.
  • Baxter Pharmaceutical Solutions LLC
  • Catalent, Inc.
  • Central Pharma Contract Packing Limited
  • Daito Pharmaceutical Co., Ltd.
  • Daklapack Group
  • Finishing Services
  • Jam Jams Group
  • Jones Healthcare Group
  • MJS Packaging
  • Nelipak Corporation
  • Nipro Corporation
  • Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • PCI Pharma Services
  • Pfizer Inc.
  • Reed-Lane, Inc.
  • Ropack Inc.
  • Sepha Limited
  • Sharp Services, LLC
  • Southwest Packaging
  • SternMaid GmbH
  • Unicep Packaging, LLC
  • Wasdell Group
  • West Pharmaceutical Services, Inc.
LSH

The Pharmaceutical Contract Packaging Market was valued at USD 32.07 billion in 2023, expected to reach USD 34.82 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 58.30 billion by 2030.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to third-party providers. This industry segment is essential because it allows pharmaceutical companies to focus on their core competencies, such as drug development and marketing, while leveraging the specialized expertise and capabilities of contract packagers in ensuring compliance with industry standards and regulations. The necessity of contract packaging stems from the increasing complexity of drug formulations and packaging requirements, heightened regulatory scrutiny, and the push towards more sustainable packaging solutions. Applications of contract packaging include blister packaging, bottle filling, labeling, and secondary packaging, with end-use scope spanning from contract manufacturing organizations (CMOs) to pharma companies producing over-the-counter (OTC) medications and prescription drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 32.07 billion
Estimated Year [2024] USD 34.82 billion
Forecast Year [2030] USD 58.30 billion
CAGR (%) 8.91%

Market insights indicate that key growth factors include heightened demand for biologics and specialty drugs necessitating innovative packaging solutions, increased outsourcing trends in the pharma industry, and advancements in packaging technologies like serialization and track-and-trace systems. Opportunities for market players include expanding service portfolios to encompass eco-friendly packaging solutions and adopting digital technologies to streamline packaging processes. Moreover, geographic expansion into emerging markets with growing pharmaceutical industries presents a lucrative prospect. However, challenges include stringent regulatory requirements, cost pressures, and demand fluctuations due to global economic uncertainties.

Innovation prospects lie in developing smart packaging solutions that enhance patient adherence, improve supply chain transparency, and facilitate authentication. Continued research into biodegradable and recyclable materials can offer a competitive edge. The nature of the market is highly competitive and dynamic, driven by rapid technological advancements and regulatory changes. For sustainable business growth, companies should invest in state-of-the-art technologies and foster strategic partnerships or alliances to enhance their service offerings. Additionally, a proactive approach to compliance and a strong focus on customer-specific needs will be critical in navigating the challenges and seizing opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Packaging Market

The Pharmaceutical Contract Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for convenient and tamper-free packaging in pharmaceutical industries
    • Rise manufacturing and export of pharmaceutical products worldwide
    • Stringent government standards for pharmaceutical packaging
  • Market Restraints
    • High cost of advanced and customized pharmaceutical contract packaging services
  • Market Opportunities
    • Technological advancements in pharmaceutical packaging solutions
    • Significant investments in drug discovery and development
  • Market Challenges
    • Newly developed drugs conflicting with packaging material and advertising forged products

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Packaging Market

A detailed market share analysis in the Pharmaceutical Contract Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Packaging Market

A strategic analysis of the Pharmaceutical Contract Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Packaging Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almac Group, AmeriPac, Inc., Aphena Pharma Solutions Inc., Assemblies Unlimited Inc., Baxter Pharmaceutical Solutions LLC, Catalent, Inc., Central Pharma Contract Packing Limited, Daito Pharmaceutical Co., Ltd., Daklapack Group, Finishing Services, Jam Jams Group, Jones Healthcare Group, MJS Packaging, Nelipak Corporation, Nipro Corporation, Patheon Pharma Services by Thermo Fisher Scientific Inc., PCI Pharma Services, Pfizer Inc., Reed-Lane, Inc., Ropack Inc., Sepha Limited, Sharp Services, LLC, Southwest Packaging, SternMaid GmbH, Unicep Packaging, LLC, Wasdell Group, and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Aluminum Foil, Glass, Paper & Paperboard, and Plastics & Polymers.
  • Based on Application, market is studied across Ampoules, Blister Packs, Bottles, and Vials.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for convenient and tamper-free packaging in pharmaceutical industries
      • 5.1.1.2. Rise manufacturing and export of pharmaceutical products worldwide
      • 5.1.1.3. Stringent government standards for pharmaceutical packaging
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced and customized pharmaceutical contract packaging services
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pharmaceutical packaging solutions
      • 5.1.3.2. Significant investments in drug discovery and development
    • 5.1.4. Challenges
      • 5.1.4.1. Newly developed drugs conflicting with packaging material and advertising forged products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Packaging Market, by Material

  • 6.1. Introduction
  • 6.2. Aluminum Foil
  • 6.3. Glass
  • 6.4. Paper & Paperboard
  • 6.5. Plastics & Polymers

7. Pharmaceutical Contract Packaging Market, by Application

  • 7.1. Introduction
  • 7.2. Ampoules
  • 7.3. Blister Packs
  • 7.4. Bottles
  • 7.5. Vials

8. Americas Pharmaceutical Contract Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almac Group
  • 3. AmeriPac, Inc.
  • 4. Aphena Pharma Solutions Inc.
  • 5. Assemblies Unlimited Inc.
  • 6. Baxter Pharmaceutical Solutions LLC
  • 7. Catalent, Inc.
  • 8. Central Pharma Contract Packing Limited
  • 9. Daito Pharmaceutical Co., Ltd.
  • 10. Daklapack Group
  • 11. Finishing Services
  • 12. Jam Jams Group
  • 13. Jones Healthcare Group
  • 14. MJS Packaging
  • 15. Nelipak Corporation
  • 16. Nipro Corporation
  • 17. Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • 18. PCI Pharma Services
  • 19. Pfizer Inc.
  • 20. Reed-Lane, Inc.
  • 21. Ropack Inc.
  • 22. Sepha Limited
  • 23. Sharp Services, LLC
  • 24. Southwest Packaging
  • 25. SternMaid GmbH
  • 26. Unicep Packaging, LLC
  • 27. Wasdell Group
  • 28. West Pharmaceutical Services, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦